Found 4 matching trials
Immunotherapy Before and After Surgery
PHASE2This Phase 2 clinical trial is testing a new immunotherapy combination (N-8...
Location
Multiple Locations
Immunotherapy With N 803, ETBX-071, and M-CENK in Combination With Radiation for Participants With High-Risk Prostate Cancer.
PHASE2This study tests a new treatment for men with high-risk prostate cancer who...
Location
Multiple Locations
Treatment of Castration Resistant Prostate Cancer Using Multi-Targeted Recombinant Ad5 PSA/MUC1/Brachyury Based Immunotherapy Vaccines
PHASE1Background:
Metastatic castration resistant prostate cancer (mCRPC) keeps ...
Location
National Institutes of Health Clinical Center
IL-15 Superagonist With or Without Vaccine in Biochemically Recurrent Prostate Cancer After Previous Stereotactic Body Radiation Therapy
PHASE2Background:
Biochemically recurrent prostate cancer (BCR) occurs when pros...
Location
National Institutes of Health Clinical Center